Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial.
鞘内注射 CRISPR 编辑的同种异体 IL-13Rα2 CAR T 细胞治疗复发性高级别胶质瘤：临床前表征和 I 期试验。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-68112-6
Li Xuetao, Shang Xiaoyun, Liu Jiangang, Zhang Yang, Jia Xian, Li Huabing, Wang Yihan, Gao Jianen, Ma Xu, Zhang Xuewen, Rong Xiaoci, Gan Wenjuan, Zhang Yu, Chen Jie, Wang Lin, Bao Zhen, He Liang, Yan Xigang, Liu Yang, Shao Jie, Xiao Zongyu, Wang Zhiming, Zhu Haiping, Wang Zhong, Wu Yuzhang, Huang Yulun
